Cogent Biosciences (COGT) Gains from Investment Securities (2017 - 2021)
Historic Gains from Investment Securities for Cogent Biosciences (COGT) over the last 5 years, with Q3 2021 value amounting to $3.7 million.
- Cogent Biosciences' Gains from Investment Securities fell 5020.37% to $3.7 million in Q3 2021 from the same period last year, while for Sep 2021 it was $3.7 million, marking a year-over-year decrease of 6154.5%. This contributed to the annual value of $100000.0 for FY2024, which is 8333.33% down from last year.
- Cogent Biosciences' Gains from Investment Securities amounted to $3.7 million in Q3 2021, which was down 5020.37% from $4.1 million recorded in Q2 2021.
- Cogent Biosciences' Gains from Investment Securities' 5-year high stood at $7.5 million during Q3 2020, with a 5-year trough of -$1000.0 in Q1 2019.
- Its 5-year average for Gains from Investment Securities is $2.4 million, with a median of $2.5 million in 2019.
- As far as peak fluctuations go, Cogent Biosciences' Gains from Investment Securities crashed by 10012.87% in 2019, and later soared by 44926630.0% in 2020.
- Cogent Biosciences' Gains from Investment Securities (Quarter) stood at $3.2 million in 2017, then grew by 16.0% to $3.7 million in 2018, then tumbled by 42.16% to $2.1 million in 2019, then plummeted by 98.91% to $23000.0 in 2020, then soared by 16057.81% to $3.7 million in 2021.
- Its last three reported values are $3.7 million in Q3 2021, $4.1 million for Q2 2021, and $2.9 million during Q1 2021.